Premarket Movers: Palantir, McDonald's, Caterpillar, and Merck Lead with Earnings

U.S. equity markets witnessed active premarket trading on Tuesday as major companies from the technology, industrial, and healthcare sectors released their second-quarter earnings. Palantir Technologies, an artificial intelligence software company, particularly captured attention with stronger-than-expected financial results and an upward revision of its full-year outlook.

Palantir Technologies (PLTR) reported adjusted earnings per share of $0.41 for the second quarter, surpassing Wall Street estimates of $0.34. The company's revenue surged 93% year-over-year to $1.94 billion, exceeding analyst forecasts of $1.81 billion. Notably, U.S. commercial revenue saw a remarkable 149% increase, underscoring accelerating demand for the company's AI platform. Management raised its full-year revenue guidance to a range of $8.15 billion to $8.16 billion. Following this robust performance, several Wall Street firms increased their price targets for Palantir stock.

Meanwhile, industrial giant Caterpillar (CAT) also climbed over 8% in premarket trading. The company posted adjusted earnings of $8.17 per share on revenue of $20.54 billion for the second quarter, topping LSEG consensus estimates of $6.20 per share and $19.34 billion, respectively. Fast-food chain McDonald's (MCD) gained after reporting adjusted earnings of $3.38 per share, beating consensus estimates of $3.32, though its revenue of $7.1 billion slightly missed the expected $7.13 billion. McDonald's global comparable sales rose 1.3%, but a slowdown in U.S. comparable sales to 0.8% was noted. Pharmaceutical giant Merck (MRK) also rose more than 1% in premarket. The company reported an adjusted loss of $0.13 per share, narrower than the expected loss of $0.26, on revenue of $16.61 billion, which surpassed estimates of $16.36 billion, and raised its full-year revenue guidance.

The strong earnings reports from these companies positively influenced overall market sentiment. Palantir's success in the AI sector, in particular, boosted optimism for technology stocks and contributed to the rise in Nasdaq futures. The solid performance of industrial companies like Caterpillar was also interpreted as benefiting from AI infrastructure demand. However, the slowdown in McDonald's U.S. sales raised concerns about consumers becoming more cautious with their spending.

While Merck's profitability was impacted by one-time accounting charges related to mergers and acquisitions, the strong sales of its key drug Keytruda and newer drug Winrevair highlighted the innovation and growth potential in the pharmaceutical sector. Overall, the released earnings statements indicate continued strong corporate performance in certain sectors despite high interest rates and global economic uncertainties. Investors will also closely monitor the earnings reports from other significant companies, such as SpaceX (SPCX) and Advanced Micro Devices (AMD), expected later in the day.

Analysts are interpreting Palantir's robust growth in the commercial segment as the 'commercial proof the market demanded,' solidifying the company's leading position in the AI software industry. Going forward, investors will closely watch whether Palantir can maintain this momentum and how its impact will extend to other players in the AI infrastructure market. For McDonald's, the critical questions will be whether the deceleration in U.S. sales growth is temporary or structural, along with management's outlook for the second half of the year and new product strategies. On Merck's front, strategies ahead of Keytruda's U.S. exclusivity expiration in 2028 and the launch of next-generation drugs will be crucial for the company's long-term growth trajectory.